{"id":{"repo_id":"utahstate","oai_identifier":"oai:digitalcommons.usu.edu:etd-4931"},"canonical_url":"https://search.ndltd.org/etd/utahstate/oai:digitalcommons.usu.edu:etd-4931","repository":{"repo_id":"utahstate","name":"Utah State University","base_url":"https://digitalcommons.usu.edu/do/oai/"},"display":{"title":"Use of Recombinant Human Granulocyte Colony Stimulating Factor as an Adjunct in Antifungal Chemotherapy in Various Animal Model Systems","abstract":"The growing neutropenic patient population provides an ideal target for opportunistic fungal infections. Several effective antifungal drugs are toxic at high doses and contraindicated for long-term treatment. Recombinant human granulocyte colony stimulating factor (rhG-CSF) has been shown to increase neutrophilic numbers and functions, thus providing enhanced host defense. Improved efficacy by using rhG-CSF in conjunction with various antifungal agents was the primary focus of these studies. Use of rhG-CSF in a murine model of vaginal candidiasis did not reduce vaginal colony counts, or improve vaginal histophathology scores. Administration of rhG-CSF in a murine model of pulmonary aspergillosis improved survival, clinical signs, and gross pathology and histophathology scores of the lungs, and increased weight gain. The rhG-CSF was not shown to be an effective therapeutic treatment in this model of vaginal candidiasis. The rhG-CSF was, however, an effective prophylactic treatment in this model of pulmonary aspergillosis.","abstract_html":"The growing neutropenic patient population provides an ideal target for opportunistic fungal infections. Several effective antifungal drugs are toxic at high doses and contraindicated for long-term treatment. Recombinant human granulocyte colony stimulating factor (rhG-CSF) has been shown to increase neutrophilic numbers and functions, thus providing enhanced host defense. Improved efficacy by using rhG-CSF in conjunction with various antifungal agents was the primary focus of these studies. Use of rhG-CSF in a murine model of vaginal candidiasis did not reduce vaginal colony counts, or improve vaginal histophathology scores. Administration of rhG-CSF in a murine model of pulmonary aspergillosis improved survival, clinical signs, and gross pathology and histophathology scores of the lungs, and increased weight gain. The rhG-CSF was not shown to be an effective therapeutic treatment in this model of vaginal candidiasis. The rhG-CSF was, however, an effective prophylactic treatment in this model of pulmonary aspergillosis.","abstract_has_math":false,"creators":["Farrell, Lindi"],"institution":"Hosted by Utah State University Libraries","degree_name":"Master of Science (MS)","degree_level":"Thesis","degree_discipline":"Animal, Dairy, and Veterinary Sciences","degree_department":null,"school":null,"contributors":["Stanley D. Allen","Donald V. Sisson","Ross A. Smart"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:48:19Z","subjects":["use","recombinant","human","granulocyte","colony","stimulating","factor","adjunct","antifungal","chemotherapy","various","animal","model","systems","Animal Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.26076/e4cf-6cf3"],"render_values":[{"text":"https://doi.org/10.26076/e4cf-6cf3","href":"https://doi.org/10.26076/e4cf-6cf3","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usu.edu/etd/3914","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usu.edu/etd/3914","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usu.edu%3Aetd-4931","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Stanley D. Allen","Donald V. Sisson","Ross A. Smart"]},{"key":"dc:creator","label":"Author","values":["Farrell, Lindi"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2010-01-01T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["1995-05-01T07:00:00Z"]},{"key":"dc:publisher","label":"Institution","values":["Hosted by Utah State University Libraries"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Animal, Dairy, and Veterinary Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["use","recombinant","human","granulocyte","colony","stimulating","factor","adjunct","antifungal","chemotherapy","various","animal","model","systems","Animal Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usu.edu/etd/3914"]},{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.26076/e4cf-6cf3"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The growing neutropenic patient population provides an ideal target for opportunistic fungal infections. Several effective antifungal drugs are toxic at high doses and contraindicated for long-term treatment. Recombinant human granulocyte colony stimulating factor (rhG-CSF) has been shown to increase neutrophilic numbers and functions, thus providing enhanced host defense. Improved efficacy by using rhG-CSF in conjunction with various antifungal agents was the primary focus of these studies. Use of rhG-CSF in a murine model of vaginal candidiasis did not reduce vaginal colony counts, or improve vaginal histophathology scores. Administration of rhG-CSF in a murine model of pulmonary aspergillosis improved survival, clinical signs, and gross pathology and histophathology scores of the lungs, and increased weight gain. The rhG-CSF was not shown to be an effective therapeutic treatment in this model of vaginal candidiasis. The rhG-CSF was, however, an effective prophylactic treatment in this model of pulmonary aspergillosis."]},{"key":"dc:title","label":"Title","values":["Use of Recombinant Human Granulocyte Colony Stimulating Factor as an Adjunct in Antifungal Chemotherapy in Various Animal Model Systems"]}]}],"canonical_facts":{"dc:contributor":["Stanley D. Allen","Donald V. Sisson","Ross A. Smart"],"dc:creator":["Farrell, Lindi"],"dc:date.available":["2010-01-01T08:00:00Z"],"dc:date.created":["1995-05-01T07:00:00Z"],"dc:description.abstract":["The growing neutropenic patient population provides an ideal target for opportunistic fungal infections. Several effective antifungal drugs are toxic at high doses and contraindicated for long-term treatment. Recombinant human granulocyte colony stimulating factor (rhG-CSF) has been shown to increase neutrophilic numbers and functions, thus providing enhanced host defense. Improved efficacy by using rhG-CSF in conjunction with various antifungal agents was the primary focus of these studies. Use of rhG-CSF in a murine model of vaginal candidiasis did not reduce vaginal colony counts, or improve vaginal histophathology scores. Administration of rhG-CSF in a murine model of pulmonary aspergillosis improved survival, clinical signs, and gross pathology and histophathology scores of the lungs, and increased weight gain. The rhG-CSF was not shown to be an effective therapeutic treatment in this model of vaginal candidiasis. The rhG-CSF was, however, an effective prophylactic treatment in this model of pulmonary aspergillosis."],"dc:identifier":["https://digitalcommons.usu.edu/etd/3914"],"dc:identifier.doi":["https://doi.org/10.26076/e4cf-6cf3"],"dc:publisher":["Hosted by Utah State University Libraries"],"dc:subject":["use","recombinant","human","granulocyte","colony","stimulating","factor","adjunct","antifungal","chemotherapy","various","animal","model","systems","Animal Sciences"],"dc:title":["Use of Recombinant Human Granulocyte Colony Stimulating Factor as an Adjunct in Antifungal Chemotherapy in Various Animal Model Systems"],"thesis:degree_discipline":["Animal, Dairy, and Veterinary Sciences"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-11-19T08:48:19Z"}